Peter Voldness | The Board and CEO of VTM Capital Management, Inc.


Has structured and funded over 150 ventures and raised over $450 million dollars for start- up and development stage companies including life sciences, encompassing genotyping, gene editing, regenerative medicine, logistics for clinical trial support and medical devices. His background is corporate finance, capital formation, both private and public finance, acquisitions

Ratings

0/5 (0 votes)
0/5 (0 votes)